Evans, Gregory W.

Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction: A Meta-analysis

Den Ruijter, H. M., Peters, S. A. E., Anderson, T. J., Britton, A. R., Dekker, J. M., Eijkemans, M. J., Engström, G., Evans, G. W., de Graaf, J., Grobbee, D. E., et al. (2012) · JAMA

Cardiovascular Health and Disease PreventionHealth Promotion and Cardiovascular Prevention

Cited by 760

Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Pop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., et al. (2010) · Diabetes Care

Heart Rate Variability and Autonomic ControlDiabetes Management and Research

Cited by 540

Diabetes, Glucose, Insulin, and Heart Rate Variability

Schroeder, E. B., Chambless, L. E., Liao, D., Prineas, R. J., Evans, G. W., Rosamond, W. D., & Heiss, G. (2005) · Diabetes Care

Heart Rate Variability and Autonomic ControlDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 302

Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial

Margolis, K. L., O’Connor, P. J., Morgan, T. M., Buse, J. B., Cohen, R. M., Cushman, W. C., Cutler, J. A., Evans, G. W., Gerstein, H. C., Grimm, R. H., et al. (2014) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 259

Multiple Metabolic Syndrome Is Associated With Lower Heart Rate Variability: The Atherosclerosis Risk in Communities Study

Liao, D., Sloan, R. P., Cascio, W. E., Folsom, A. R., Liese, A. D., Evans, G. W., Cai, J., & Sharrett, A. R. (1998) · Diabetes Care

Heart Rate Variability and Autonomic ControlDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 223

Relationships of Cerebral MRI Findings to Ultrasonographic Carotid Atherosclerosis in Older Adults: The Cardiovascular Health Study

Manolio, T. A., Burke, G. L., O’Leary, D. H., Evans, G., Beauchamp, N., Knepper, L., & Ward, B. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology

Cerebrovascular and Carotid Artery DiseasesCardiovascular Health and Disease Prevention

Cited by 194

Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models

Peters, S. A. E., Bots, M. L., den Ruijter, H. M., Palmer, M. K., Grobbee, D. E., Crouse, J. R., O’Leary, D. H., Evans, G. W., Raichlen, J. S., Moons, K. G. M., et al. (2012) · Journal of Clinical Epidemiology

Statistical Methods and Bayesian InferenceStatistical Methods in Clinical Trials

Cited by 165

Rationale and Design for the Blood Pressure Intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Cushman, W. C., Grimm, R. H., Cutler, J. A., Evans, G. W., Capes, S., Corson, M. A., Sadler, L. S., Alderman, M. H., Peterson, K., Bertoni, A., et al. (2007) · The American Journal of Cardiology

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 123

Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial

Sink, K. M., Evans, G. W., Shorr, R. I., Bates, J. T., Berlowitz, D., Conroy, M. B., Felton, D. M., Gure, T., Johnson, K. C., Kitzman, D., et al. (2018) · Journal of the American Geriatrics Society

Blood Pressure and Hypertension StudiesCardiovascular Syncope and Autonomic Disorders

Cited by 92

The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures

Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29